Titre:
  • Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Auteur:Olender, Susan Aileen; Perez, Katherine K.K.; Go, Alan A.S.; Balani, Bindu; Price-Haywood, Eboni E.G.; Shah, Nirav N.S.; Wang, Su; Walunas, Theresa T.L.; Swaminathan, Shobha; Slim, Jihad; Chin, Bum Sik; De Wit, Stéphane; Ali, Shamim S.M.; Soriano Viladomiu, Alex; Robinson, Philip; Gottlieb, Robert R.L.; Tsang, Tak Yin Owen; Lee, Heng I.H.; Hu, Hao; Haubrich, Richard; Chokkalingam, Anand A.P.; Lin, Lanjia; Zhong, Lijie; Bekele, Benjamin Nebiyou; Mera-Giler, Robertino; Phulpin, Chloé; Edgar, Holly; Gallant, Joel J.E.; Diaz-Cuervo, Helena; Smith, Lindsey L.E.; Osinusi, Anu A.O.; Brainard, Diana D.M.; Bernardino, José Ignacio
Informations sur la publication:Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73, 11, page (e4166-e4174)
Statut de publication:Publié, 2021-12
Sujet CREF:Pathologie maladies infectieuses
Microbiologie et protistologie [bacteriol.,virolog.,mycolog.]
Microbiologie et protistologie [entomologie,phytoparasitolog.]
Microbiologie et protistologie [parasitologie hum. et anim.]
Mots-clés:antiviral treatment
remdesivir
SARS-CoV-2
severe COVID-19
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1537-6591
info:doi/10.1093/cid/ciaa1041
info:scp/85122546252
info:pmid/32706859